G.CroteauD
On X, physician-scientist Eric Topol called the vote baseless, warning it legitimizes therapies without clinical evidence
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met + SU): a randomised controlled trial
Vestergaard et al., 2010 quantified 11 common pathogenic DNA viruses in the eutopic endometrium of endometriosis cases and controls, and ectopic lesions, revealing low viral prevalence, no significant differences between cases and controls, and no viruses recovered from ectopic lesions
Side effects are typically rare and mild, such as slight pain at the injection site or mild dizziness
Whilst current evidence shows no established causal link between GLP-1 agonist use and these haematological conditions, individualised assessment remains essential for patients with existing lymphoproliferative disorders or those at risk